Aligos Therapeutics Inc (NAS:ALGS)
$ 14.61 0.58 (4.13%) Market Cap: 46.70 Mil Enterprise Value: -40.05 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 51/100

Aligos Therapeutics Inc ALGS Going Public Transcript

Oct 16, 2020 / 10:59 AM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ALGS.OQ - Aligos Therapeutics Inc
Aligos Therapeutics Inc ALGS Going Public
Oct 16, 2020 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Participant [1]
--------------------------------------------------------------------------------
Hello, everyone, and welcome to IPO Market Watch. If you are new to this channel, this channel covers all initial public offerings, IPOs; direct listings; and SPACs, special purpose acquisition companies, or otherwise known as blank check companies. And we do video reviews for each of the private companies that go public in either way IPO, a blank check company, et cetera. And I also do videos to remind you guys of when they are going public, just like in this video where we are going to learn about Aligos Therapeutics and the fact that they are going public on October 16, 2020, which is tomorrow, under ticker symbol ALGS.

So the mission of Aligos Therapeutics is to become a world leader in development of targeted
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot